PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18817066-4	2008	The single Cd2+ and Pb2+ treatments significantly inhibited dehydrogenase activities at concentrations in excess of 20 micromol/L Cd2+ and 80 micromol/L Pb2+, respectively.	Lead	20-24	CD2 molecule	Homo sapiens	130-133	
18817066-4	2008	The single Cd2+ and Pb2+ treatments significantly inhibited dehydrogenase activities at concentrations in excess of 20 micromol/L Cd2+ and 80 micromol/L Pb2+, respectively.	Lead	153-157	CD2 molecule	Homo sapiens	11-14	
18817066-6	2008	At the same time, the combined treatment of Cd2+ and Pb2+ significantly inhibited dehydrogenase activities at all five concentrations studied and the lowest combined concentration was 1.25 micromol/L Cd2+ and 5 micromol/L Pb2+.	Lead	53-57	CD2 molecule	Homo sapiens	200-203	
18817066-6	2008	At the same time, the combined treatment of Cd2+ and Pb2+ significantly inhibited dehydrogenase activities at all five concentrations studied and the lowest combined concentration was 1.25 micromol/L Cd2+ and 5 micromol/L Pb2+.	Lead	222-226	CD2 molecule	Homo sapiens	44-47